Neurology news, research and treatment studies for MS, epilepsy, dementia, stroke and other brain and CNS disorders and diseases.

5 days ago · References: FDA approves Leqembi ® (lecanemab-irmb) IV maintenance dosing for the treatment of early Alzheimer’s disease. News release. Eisai Inc. January 26, 2025. https://www.prnewswire.com ...

5 days ago · Transcutaneous auricular vagus nerve stimulation (taVNS) significantly reduced insomnia severity, according to a small, sham-controlled trial published in JAMA Network Open.. Investigators ...

Feb 11, 2022 · Several studies provide evidence for neurologic and neuropsychiatric morbidity during and after COVID-19 infection—a phenomenon known as “long-haul COVID.” 1 People with long-haul COVID are ...

Jul 7, 2020 · Despite the devastating global impact of coronavirus disease 2019 (COVID-19), there remains knowledge gaps on the range of complications the virus may have on various organs and body systems ...

Jan 28, 2025 · Long COVID neurologic symptoms including fatigue, sleep disturbance, and executive function, were more common among adults aged 18 to 64 vs those aged 65 and older. Younger and middle-aged ...

Feb 3, 2025 · Altered cue-elicited event-related potentials (ERPs) may predict phenoconversion among patients with isolated rapid eye movement (REM) sleep behavior disorder (iRBD), according to study results ...

Jan 23, 2025 · Average life expectancy for patients with dementia ranges from 8.9 years after diagnosis at a mean age of 60 years for women to 2.2 years at a mean age of 85 years for men.

Jan 29, 2025 · If administered within the COVID-19 convalescence period, the intradermal Bacillus Calmette-Guérin (BCG) vaccine is protective against long COVID development among adults with mild COVID-19 ...

Sep 29, 2023 · Among patients with a Lyme disease diagnosis, up to 15% will develop Lyme neuroborreliosis, an infectious disease that affects the central nervous system (CNS). 1-3 Lyme neuroborreliosis, which is ...